Skip to main content

UC Davis Comprehensive Cancer Center

Diana L. Miglioretti, Ph.D. View profile as PDF

Diana L. Miglioretti

Clinical Interests

Dr. Miglioretti’s primary methodological research interests are in multilevel and latent variable models, longitudinal and clustered data analysis, and the evaluation of screening and diagnostic tests. The majority of her collaborative research is in the areas of breast cancer screening and radiation exposure from medical imaging.


Dean's Professor in Biostatistics


Public Health Sciences- Division of Biostatistics


Public Health Sciences


UC Davis School of Medicine - Medical Sciences 1C

Davis, CA 95616
Driving Directions

Additional Phone:

Phone: 530-752-7168
Phone: 530-754-5664
Fax: 530-752-3239


Ph.D., Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore MD 2000
Sc.M., Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore MD 1996
B.S., University of Maryland, College Park MD 1992
B.S., University of Maryland, College Park MD 1992

Professional Memberships:

American Association for Cancer Research
American Statistical Association
Radiation Research Society
The International Biometric Society Eastern North American Region
The International Biometric Society Western North American Region

Select Honors and Awards:

UC Davis School of Medicine Research Award, 2017

North American Primary Care Research Group (NAPCRG) Pearl Award, 2015

Herbert M. Stauffer Award for Best Clinical Paper, 2014

Top 10 publication funded by NCI’s Epidemiology and Genomics Research Program, 2013

Minnies Runner-up for Scientific Paper of the Year, 2013

Top 10 AuntMinnie stories, 2013

Minnies semifinalist for the “Most Influential Radiology Researcher”, 2013

Select Recent Publications:

Miglioretti DL, Ichikawa L, Smith R, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas B, Kerlikowske K. “Correlation between screening mammography interpretive performance on a test set and performance in clinical practice.” Acad Radiol. 2017 May 24. [Epub ahead of print]

Smith-Bindman R, Wang Y, Yellen-Nelson TR, Moghadassi M, Wilson N, Gould R, Seibert A, Boone JM, Krishnam M, Lamba R, Hall DJ, Miglioretti DL. “Predictors of CT Radiation Dose and Their Effect on Patient Care: A Comprehensive Analysis Using Automated Data.” Radiology. 2017 Jan;282(1):182-193. Epub 2016 Jul 20.

Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. “Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy” JAMA Oncol. 2017 Jan 1;3(1):36-41. Epub 2016 Sept 8.

Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. “Statistical methods for estimating the cumulative risk of screening mammography outcomes.” Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):513-20. Epub 2015 Dec 31.

Miglioretti DL, Lang J, van den Broek JJ, Lee CI, van Ravesteyn N, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA, “Radiation-Induced Breast Cancer Incidence and Mortality from Digital Mammography Screening: A Modeling Study.” Ann Intern Med. 2016 Feb 16;164(4):205-14. Epub 2016 Jan 12.

Nelson HD, O’Meara ES, Kerlikowske K, Balch S, Miglioretti D. “Factors affecting the rates and consequences of false positive and false negative digital mammography screening exams: An analysis of registry data.” Ann Intern Med. 2016 Feb 16;164(4):226-35. Epub 2016 Jan 12.

Lehman C, Wellman RD, Buist DSM, Kerlikowske K, Tosteson ANA, Miglioretti DL, Breast Cancer Surveillance Consortium. “Diagnostic Accuracy of Digital Screening Mammography with and without Computer-aided Detection.” JAMA Internal Medicine. 2015 Sep 28:1-10.

Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DSM, Henderson LM, Smith RA, Breast Cancer Surveillance Consortium. “Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.” JAMA Oncol. 2015 Nov 1;1(8):1069-77.

Tice J, Miglioretti DL, Li C, Vachon C, Gard C, Kerlikowske K. “Breast density and benign breast disease: Risk assessment to identify women at high risk of breast cancer.” J Clin Oncol. 2015 Oct 1; 33(28):3137-43. Epub 2015 Aug 17.